Literature DB >> 15191945

Platelet-associated CD154 in immune thrombocytopenic purpura.

Anne Solanilla1, Jean-Max Pasquet, Jean-François Viallard, Cécile Contin, Christophe Grosset, Julie Déchanet-Merville, Maryse Dupouy, Marc Landry, Francis Belloc, Paquita Nurden, Patrick Blanco, Jean-François Moreau, Jean-Luc Pellegrin, Alan T Nurden, Jean Ripoche.   

Abstract

CD40-ligand (CD154) is expressed on activated CD4+ T lymphocytes and is essential for the T cell-dependent activation of B lymphocytes. CD154 is also expressed at the activated platelet surface. In this study, we show that platelet-associated CD154 is increased in immune thrombocytopenic purpura (ITP), a disease characterized by an autoimmune response against proteins of the platelet membrane. CD154 and its messenger RNA were also present in increased amounts in the megakaryocytes of patients with ITP. We found that platelet-associated CD154 is competent to induce the CD40-dependent proliferation of B lymphocytes, and we observed an in vitro CD154-dependent production of antibodies to the GPIIb/IIIa complex (integrin alphaIIbbeta3) when platelets and peripheral blood B lymphocytes from ITP patients with circulating anti-GPIIb/IIIa antibody were cultured together. Therefore, platelet-associated CD154 expression is increased in ITP and is able to drive the activation of autoreactive B lymphocytes in this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191945     DOI: 10.1182/blood-2003-07-2367

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Platelet CD40L at the interface of adaptive immunity.

Authors:  Bennett D Elzey; Timothy L Ratliff; Jennifer M Sowa; Scott A Crist
Journal:  Thromb Res       Date:  2010-11-13       Impact factor: 3.944

Review 2.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

3.  Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.

Authors:  X Feng; P Scheinberg; L Samsel; O Rios; J Chen; J P McCoy; W Ghanima; J B Bussel; N S Young
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 4.  The role of platelet CD154 in the modulation in adaptive immunity.

Authors:  Daniel L Sprague; Jennifer M Sowa; Bennett D Elzey; Timothy L Ratliff
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.

Authors:  Daniel L Sprague; Bennett D Elzey; Scott A Crist; Thomas J Waldschmidt; Robert J Jensen; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 6.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

7.  Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.

Authors:  Zhenhai Zhou; Xiaoyin Li; Juan Li; Chang Su; Lan Zhuang; Shaokai Luo; Ling Zhang
Journal:  J Clin Immunol       Date:  2010-07-14       Impact factor: 8.317

8.  Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

Authors:  Johnson Q Tran; Marcus O Muench; Rachael P Jackman
Journal:  Blood Adv       Date:  2020-11-10

9.  Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154.

Authors:  Ilaria Deambrosis; Sara Lamorte; Fulvia Giaretta; Lorenzo Tei; Luigi Biancone; Benedetta Bussolati; Giovanni Camussi
Journal:  J Mol Med (Berl)       Date:  2008-11-05       Impact factor: 4.599

Review 10.  The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.

Authors:  Neil Blumberg; Sherry L Spinelli; Charles W Francis; Mark B Taubman; Richard P Phipps
Journal:  Immunol Res       Date:  2009-01-29       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.